These results expose some molecular mechanisms underlying CSF-induced plasticity in GBM cells and demonstrate that inhibiting the transcriptional regulator NUPR1 can improve the efficacy of current chemoradiotherapies for GBM in a neuronal microenvironment. The gene discussed is NUPR1; the disease is glioblastoma.